NasdaqCM - Delayed Quote • USD
ARCA biopharma, Inc. (ABIO)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 4:57 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Sep 2020) | Next Qtr. (Dec 2020) | Current Year (2020) | Next Year (2021) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -0.76 | -0.77 | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Sep 2020) | Next Qtr. (Dec 2020) | Current Year (2020) | Next Year (2021) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 9/30/2019 | 12/31/2019 | 3/31/2020 | 6/30/2020 |
---|---|---|---|---|
EPS Est. | -1.3 | -0.99 | -2.04 | -2.58 |
EPS Actual | -0.76 | -0.77 | -0.83 | -0.73 |
Difference | 0.54 | 0.22 | 1.21 | 1.85 |
Surprise % | 41.50% | 22.20% | 59.30% | 71.70% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Sep 2020) | Next Qtr. (Dec 2020) | Current Year (2020) | Next Year (2021) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | -2.51 | -2.44 | -9.59 | -8.8 |
30 Days Ago | -2.51 | -2.44 | -9.59 | -8.8 |
60 Days Ago | -2.51 | -2.44 | -9.59 | -8.8 |
90 Days Ago | -2.51 | -2.44 | -9.59 | -8.8 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Sep 2020) | Next Qtr. (Dec 2020) | Current Year (2020) | Next Year (2021) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ABIO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 2.60% |
Next Qtr. | -- | -- | -- | 13.40% |
Current Year | -- | -- | -- | 5.20% |
Next Year | -- | -- | -- | 13.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.11% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Initiated | Dawson James: Buy | 10/9/2013 |
Related Tickers
KTRA Kintara Therapeutics, Inc.
0.1580
+15.08%
PHIO Phio Pharmaceuticals Corp.
0.7060
+5.22%
LGVN Longeveron Inc.
1.6700
-2.91%
CLNN Clene Inc.
0.3465
+2.82%
JAGX Jaguar Health, Inc.
0.1700
+0.06%
PXMD PaxMedica, Inc.
0.7042
+1.76%
CADL Candel Therapeutics, Inc.
6.43
+6.28%
NKGN NKGen Biotech, Inc.
1.9800
+15.79%
ACRV Acrivon Therapeutics, Inc.
8.47
-10.84%
GRTX Galera Therapeutics, Inc.
0.2075
+13.57%